AEMD : Summary for AETHLON MEDICAL INC - Yahoo Finance

U.S. Markets open in 4 hrs 53 mins

Aethlon Medical, Inc. (AEMD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.42+0.07 (+2.09%)
At close: 4:00PM EDT
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close3.35
Bid0.00 x
Ask3.45 x 500
Day's Range3.27 - 3.44
52 Week Range3.10 - 9.09
Avg. Volume34,457
Market Cap26.62M
PE Ratio (TTM)-3.87
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire15 days ago

    Aethlon Medical Announces The Conclusion Of Hemopurifier Clinical Study

    SAN DIEGO, March 13, 2017 /PRNewswire/ -- Aethlon Medical, Inc. (AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that the company has concluded an FDA-approved feasibility study designed to assess the safety of the Aethlon Hemopurifier® in health-compromised individuals. The Hemopurifier is a first-in-class medical device that reduces the presence of circulating viruses in infected individuals. The technology is a first-line candidate defense against a broad-spectrum of viruses that are not addressed with antiviral drug therapies, including natural occurring pandemic threats and agents of bioterrorism.  Additionally, the device provides a strategy to augment the benefit of proven antiviral drug regimens.

  • PR Newswire20 days ago

    Aethlon Medical To Present At ROTH Capital Partners 29th Annual Growth Stock Conference On March 14, 2017

    SAN DIEGO, March 8, 2017 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), today announced that Jim Joyce, Chairman and CEO, will be presenting at the ROTH Capital Partners 29th Annual Growth Stock ...

  • PR Newswire27 days ago

    Aethlon Medical Announces the Grant of a European Patent Protecting Methods of Quantifying Exosomes

    SAN DIEGO, March 1, 2017 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), announced today that the European Patent Office has granted European Patent Number 2591359, entitled "METHODS AND COMPOSITIONS ...